Addus HomeCare (NASDAQ:ADUS) Upgraded to Strong-Buy at KeyCorp

KeyCorp upgraded shares of Addus HomeCare (NASDAQ:ADUS) to a strong-buy rating in a report published on Thursday, Zacks.com reports.

Several other brokerages have also commented on ADUS. Macquarie restated an outperform rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Friday. Oppenheimer increased their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an outperform rating in a research note on Monday, September 23rd. StockNews.com lowered shares of Addus HomeCare from a strong-buy rating to a buy rating in a research note on Sunday, July 7th. Royal Bank of Canada restated an outperform rating and set a $141.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Finally, Stephens restated an overweight rating and set a $138.00 price target on shares of Addus HomeCare in a research note on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and an average target price of $131.38.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $130.63 on Thursday. The firm has a market cap of $2.36 billion, a PE ratio of 32.41, a P/E/G ratio of 2.33 and a beta of 1.04. The firm’s 50 day moving average price is $129.54 and its two-hundred day moving average price is $117.34. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.94 EPS. Equities analysts anticipate that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares in the company, valued at $429,165. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 22,917 shares of company stock worth $3,050,082. 4.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Ellsworth Advisors LLC bought a new position in Addus HomeCare during the 2nd quarter worth approximately $598,000. Quadrature Capital Ltd acquired a new stake in shares of Addus HomeCare in the first quarter valued at approximately $1,557,000. Lord Abbett & CO. LLC acquired a new stake in shares of Addus HomeCare in the first quarter valued at approximately $8,274,000. Vanguard Group Inc. raised its holdings in shares of Addus HomeCare by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after purchasing an additional 38,876 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at approximately $842,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.